The election of the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria will move forward on schedule, according to a statement released by the organisation on Tuesday, 7 July. This announcement follows rumours that the nomination process might be restarted after the names of several US candidates who were reportedly shortlisted had been disclosed to Health Policy Watch

The roster reportedly omitted a German-backed applicant, sparking frustration in European countries, particularly in Germany, a major donor to the Global Fund.  See related story.

EXCLUSIVE: US Candidates Among Those Shortlisted in Contentious Global Fund Leadership Race

Also on Tuesday, the Trump administration confirmed that it will not impose its expanded global gag rule or other funding conditions on its contributions to the Global Fund, according to a Devex report. The expanded rule, adopted by President Donald Trump last year, restricts the use of US funding not only for abortions but to global health programmes that promote diversity, equity and inclusion – language that hits at the very DNA of most global health initiatives.

Calls for more transparency

Because the multibillion-dollar agency relies heavily on taxpayer contributions to procure lifesaving medicines, some critics have maintained that the Global Fund leadership race should be conducted in a more transparent manner.

Defending its restrictive protocols, the Global Fund statement contended that absolute confidentiality is essential to protect the privacy of high-profile applicants and safeguard the integrity of the proceedings by the Executive Director Nominating Committee (EDNC).

“The Global Fund remains committed to a merit-based, transparent and well-governed selection process that protects the confidentiality of candidates while enabling the Board to identify the strongest possible leader for the organization,” the statement said.

“The names and biographies of the final shortlisted candidates will be published on the Global Fund website once it has been submitted to the Board. Until that stage, candidate information and committee deliberations will remain confidential to protect the integrity of the process, ensure fairness to all candidates and support open deliberations by the EDNC. Other than the final candidates, all other candidate names remain confidential indefinitely,” the statement added.  A final shortlist of “four to five candidates” should be submitted to the Board in late September, the statement added.

The strict confidentiality rules stem from a costly historical precedent, supporters of the process say.  During the 2017 leadership transition, the institution was forced to completely restart its executive director search after leaks to the media.

Nomination schedule on track

As the Global Fund grapples with a massive $5.36 billion funding shortfall for the next grant cycle, the selection procedure unfolds against a highly challenging financial and geopolitical backdrop.

Moving forward, successive rounds of confidential interviews and due diligence assessments are narrowing the applicant pool behind closed doors.

First-round interviews will take place next week, from 12 to 23 July in London, followed by second-round interviews in early September to finalise the shortlist. The finalists will attend a retreat on 1 and 2 October, followed by several weeks of “engagement with Board constituencies” before the Board convenes to make a final decision.

Final appointment of the incoming executive director will then occur during the 56th board meeting in Geneva from 28 to 30 October 2026.

Assuming office during the first quarter of 2027, the newly elected Executive Director must immediately navigate a fractured donor landscape and geopolitical rifts to continue the vital work of the organisation.

New Funding Models Needed as Global Health Faces Growing Financial Strain

Image Credits: European Union.